Multivalent vaccines comprising recombinant viral vectors

Details for Australian Patent Application No. 2005305869 (hide)

Owner Crucell Holland B.V. Aeras Global TB Vaccine Foundation

Inventors Hone, David; Radosevic, Katarina; Havenga, Menzo Jans Emco; Skeiky, Yasir Abdul Wahid; Sadoff, Jerald; Vogels, Ronald

Agent Davies Collison Cave

Pub. Number AU-B-2005305869

PCT Pub. Number WO2006/053871

Priority 04106074.0 25.11.04 EP; 60/651,113 08.02.05 US; 60/628,253 16.11.04 US

Filing date 15 November 2005

Wipo publication date 26 May 2006

Acceptance publication date 9 December 2010

International Classifications

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/053871 Priority application(s): WO2006/053871

9 December 2010 Application Accepted

  Published as AU-B-2005305869

7 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005305880-Benzothiazole formulations and use thereof

2005305853-Device and method for determining material properties by means of HPLC (High Performance Liquid Chromatography)